Andy Peps Studio
Andy Peps Studio's purity-focus evidence is strongest for Tirzepatide and Retatrutide, where recent identity and high-purity results form a mostly consistent run. BPC-157 and Tesamorelin are more dispersed, with recent or earlier purity/fill misses and weaker batch traceability, so confidence is lower despite newer tests.
APS publicly disavowed an APS-branded storefront that kept operating, changed contact presentation, and showed a later WHOIS update. The report also maps linked retail infrastructure, COA provenance gaps, and forum-reputation signals.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Andy Peps Studio rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 4 Aug 2026 | Pass | Tirzepatide Andy Peps Studio | lab name | View COA | |||
| 24 Jun 2026 | Pass | Tesamorelin Andy Peps Studio | lab name | View COA | |||
| 24 Jun 2026 | Pass | Retatrutide Andy Peps Studio | lab name | View COA | |||
| 28 May 2026 | Pass | Tirzepatide Andy Peps Studio | lab name | View COA | |||
| 27 May 2026 | Fail | BPC-157 Andy Peps Studio | lab name | View COA | |||
| 19 May 2026 | Pass | Tirzepatide Andy Peps Studio | lab name | View COA | |||
| 19 May 2026 | Pass | Retatrutide Andy Peps Studio | lab name | View COA | |||
| 28 Apr 2026 | Pass | Retatrutide Andy Peps Studio | lab name | View COA | |||
| 28 Apr 2026 | Pass | BPC-157 Andy Peps Studio | lab name | View COA | |||
| 28 Apr 2026 | Pass | Tirzepatide Andy Peps Studio | lab name | View COA | |||
About Andy Peps Studio test results from Finnrick
Andy Peps Studio is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 4 peptides and 39 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Andy Peps Studio peptides in this dataset are Tirzepatide (16 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 39 recent tests.